FATE THERAPEUTICS INC (FATE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$13.29M2012: -$13.56M2013: -$17.68M2014: -$24.90M2015: -$27.78M2016: -$31.96M2017: -$42.12M2018: -$67.09M2019: -$100.73M2020: -$128.09M2021: -$216.99M2022: -$308.39M2023: -$190.51M2024: -$210.28M2025: -$147.70M-$147.70M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$147.70M+29.8%
2024-$210.28M-10.4%
2023-$190.51M+38.2%
2022-$308.39M-42.1%
2021-$216.99M-69.4%
2020-$128.09M-27.2%
2019-$100.73M-50.1%
2018-$67.09M-59.3%
2017-$42.12M-31.8%
2016-$31.96M-15.0%
2015-$27.78M-11.6%
2014-$24.90M-40.9%
2013-$17.68M-30.4%
2012-$13.56M-2.0%
2011-$13.29M